Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Spatial Memory
100%
Memory Function
100%
APPswe
100%
Acute Inhibition
100%
Phosphodiesterase
100%
GEBR-7b
100%
APPswePS1dE9
100%
Phosphodiesterase Type IV Inhibitors
50%
Alzheimer's Disease
33%
Phosphodiesterase-4 (PDE4)
33%
CAMP Response Element-binding Protein
33%
Alzheimer's Disease Model
33%
Phosphorylation
16%
Treatment Strategy
16%
Beneficial Effects
16%
Cognitive Deficits
16%
Brain-derived Neurotrophic Factor
16%
Factor Level
16%
Memory Formation
16%
Synaptic Plasticity
16%
Novel Therapeutics
16%
Affective Behavior
16%
Clinical Development
16%
Postsynaptic Density Protein 95 (PSD-95)
16%
Glycogen Synthase kinase-3β (GSK-3β)
16%
Isoform-specific
16%
Hippocampus
16%
Object Location Test
16%
Protein Phosphorylation
16%
Cognitive Behavior
16%
Tau Phosphorylation
16%
Cognition Enhancer
16%
Subcutaneous Injection
16%
Level Density
16%
Intracellular Signal Transduction
16%
INIS
mice
100%
inhibition
100%
phosphodiesterases
100%
boron 7
100%
levels
66%
nervous system diseases
66%
phosphorylation
50%
proteins
50%
doses
16%
increasing
16%
side effects
16%
brain
16%
density
16%
signals
16%
vehicles
16%
breakdown
16%
hippocampus
16%
transcription
16%
plasticity
16%
subcutaneous injection
16%
Neuroscience
Phosphodiesterase
100%
Alzheimer's Disease
100%
Spatial Memory
100%
Cyclic Adenosine Monophosphate
75%
Phosphodiesterase-4 Inhibitor
75%
Response Element
50%
Protein Binding
50%
Emetic Agent
50%
Synaptic Plasticity
25%
Enhancer Region
25%
Behavior (Neuroscience)
25%
Cognitive Disorders
25%
Hippocampus
25%
Brain-Derived Neurotrophic Factor
25%
Protein Phosphorylation
25%
Signal Transduction
25%